IL1R1 and myeloid sarcoma: Whether endothelial IL-1R1 is a critical mediator of MS pathogenesis is still a matter of debate, but these studies show that IL-1R1 activation in endothelial cells is fundamental for myeloid cell recruitment and BBB disruption, amplifying the neuroinflammatory response.